2022 Q1 Form 10-Q Financial Statement

#000161600022000073 Filed on May 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $210.3M $87.85M
YoY Change 139.43% -59.21%
Cost Of Revenue $141.6M $77.08M
YoY Change 83.7% -54.88%
Gross Profit $68.74M $10.77M
YoY Change 538.37% -75.8%
Gross Profit Margin 32.68% 12.26%
Selling, General & Admin $69.27M $47.10M
YoY Change 47.07% -44.98%
% of Gross Profit 100.77% 437.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $30.43M $32.93M
YoY Change -7.59% -9.65%
% of Gross Profit 44.27% 305.8%
Operating Expenses $99.84M $80.20M
YoY Change 24.49% -34.58%
Operating Profit $17.74M -$39.18M
YoY Change -145.28% 24.2%
Interest Expense $20.54M $18.75M
YoY Change 9.54% 43.96%
% of Operating Profit 115.78%
Other Income/Expense, Net -$777.0K $116.0K
YoY Change -769.83% -8.66%
Pretax Income -$3.870M -$57.81M
YoY Change -93.31% 30.09%
Income Tax $1.600M $200.0K
% Of Pretax Income
Net Earnings -$5.324M -$56.35M
YoY Change -90.55% 55.93%
Net Earnings / Revenue -2.53% -64.14%
Basic Earnings Per Share -$0.05 -$0.50
Diluted Earnings Per Share -$0.05 -$0.50
COMMON SHARES
Basic Shares Outstanding 114.3M shares 113.8M shares
Diluted Shares Outstanding 114.3M shares 113.8M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $179.1M $354.6M
YoY Change -49.5% -10.64%
Cash & Equivalents $179.1M $354.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $36.24M $14.60M
Other Receivables $0.00 $0.00
Total Short-Term Assets $215.3M $369.2M
YoY Change -41.68% -12.16%
LONG-TERM ASSETS
Property, Plant & Equipment $2.728B $2.562B
YoY Change 6.52% -13.45%
Goodwill $4.850M
YoY Change -43.5%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $40.16M $34.60M
YoY Change 16.06% -56.48%
Total Long-Term Assets $2.825B $2.654B
YoY Change 6.45% -14.3%
TOTAL ASSETS
Total Short-Term Assets $215.3M $369.2M
Total Long-Term Assets $2.825B $2.654B
Total Assets $3.040B $3.023B
YoY Change 0.57% -14.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $92.82M $61.60M
YoY Change 50.68% -22.22%
Accrued Expenses $20.64M $23.80M
YoY Change -13.29% -12.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $113.5M $85.40M
YoY Change 32.85% -38.16%
LONG-TERM LIABILITIES
Long-Term Debt $1.430B $1.374B
YoY Change 4.05% -15.85%
Other Long-Term Liabilities $58.61M $49.70M
YoY Change 17.93% -23.54%
Total Long-Term Liabilities $1.488B $1.424B
YoY Change 4.53% -16.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $113.5M $85.40M
Total Long-Term Liabilities $1.488B $1.424B
Total Liabilities $1.602B $1.509B
YoY Change 6.14% -17.8%
SHAREHOLDERS EQUITY
Retained Earnings -$661.8M -$569.4M
YoY Change 16.23% 47.55%
Common Stock $1.144M $1.138M
YoY Change 0.53% 0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.429B $1.501B
YoY Change
Total Liabilities & Shareholders Equity $3.040B $3.023B
YoY Change 0.57% -14.04%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$5.324M -$56.35M
YoY Change -90.55% 55.93%
Depreciation, Depletion And Amortization $30.43M $32.93M
YoY Change -7.59% -9.65%
Cash From Operating Activities $32.57M -$31.16M
YoY Change -204.53% -678.43%
INVESTING ACTIVITIES
Capital Expenditures -$336.0M -$7.200M
YoY Change 4566.56% -67.57%
Acquisitions
YoY Change
Other Investing Activities $34.90M $700.0K
YoY Change 4885.71% -65.0%
Cash From Investing Activities -$301.1M -$6.547M
YoY Change 4498.93% -67.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$66.48M -$1.854M
YoY Change 3485.54% -100.63%
NET CHANGE
Cash From Operating Activities $32.57M -$31.16M
Cash From Investing Activities -$301.1M -$6.547M
Cash From Financing Activities -$66.48M -$1.854M
Net Change In Cash -$335.0M -$39.56M
YoY Change 746.78% -114.06%
FREE CASH FLOW
Cash From Operating Activities $32.57M -$31.16M
Capital Expenditures -$336.0M -$7.200M
Free Cash Flow $368.6M -$23.96M
YoY Change -1638.25% -186.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001616000
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2022Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
CY2022Q1 dei City Area Code
CityAreaCode
407
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
246-8100
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-36594
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Xenia Hotels & Resorts, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0141677
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
200 S. Orange Avenue
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2700
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q1 dei Trading Symbol
TradingSymbol
XHR
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114353273 shares
CY2022Q1 us-gaap Land
Land
467708000 USD
CY2021Q4 us-gaap Land
Land
431427000 USD
CY2022Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3160421000 USD
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2856671000 USD
CY2022Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3628129000 USD
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3288098000 USD
CY2022Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
919045000 USD
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
888717000 USD
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2709084000 USD
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2399381000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179077000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
517377000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40158000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
36854000 USD
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
36242000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
28528000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2352000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2231000 USD
CY2022Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5414000 USD
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5446000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
70112000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
65109000 USD
CY2022Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
34621000 USD
CY2022Q1 us-gaap Assets
Assets
3040087000 USD
CY2021Q4 us-gaap Assets
Assets
3087316000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1429616000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1494231000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
92818000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
84051000 USD
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
79248000 USD
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
68648000 USD
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
2305000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1601682000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1649235000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114353273 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114353273 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114306727 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114306727 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1144000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1143000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2090627000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2090393000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-837000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4089000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-661785000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-656461000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1429149000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1430986000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
9256000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
7095000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1438405000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1438081000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3040087000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3087316000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
210347000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87852000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
141607000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
77084000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30565000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33197000 USD
CY2022Q1 xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
10855000 USD
CY2021Q1 xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
10540000 USD
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
517000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
403000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7786000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6922000 USD
CY2022Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 USD
CY2021Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
1116000 USD
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1278000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
192608000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
127030000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17739000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-39178000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-777000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
116000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
20538000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
18750000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-294000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3870000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57812000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1607000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
165000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-57977000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-153000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1626000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5324000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56351000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114326406 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114326406 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113780388 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113780388 shares
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-57977000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2517000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
104000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1152000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-2330000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1808000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-55543000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
264000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1558000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2072000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53985000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1438081000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2435000 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
303000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2517000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1152000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1438405000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1566863000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-57977000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2685000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
318000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
104000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-2330000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1513687000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-5477000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-57977000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
30429000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
32929000 USD
CY2022Q1 xhr Noncash Ground Rent And Amortization Of Other Intangibles
NoncashGroundRentAndAmortizationOfOtherIntangibles
136000 USD
CY2021Q1 xhr Noncash Ground Rent And Amortization Of Other Intangibles
NoncashGroundRentAndAmortizationOfOtherIntangibles
268000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1286000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1767000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-294000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2022Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
994000 USD
CY2021Q1 us-gaap Insurance Recoveries
InsuranceRecoveries
0 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2207000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2295000 USD
CY2022Q1 xhr Interest Expense Noncash
InterestExpenseNoncash
-409000 USD
CY2021Q1 xhr Interest Expense Noncash
InterestExpenseNoncash
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
7599000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
5604000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5315000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8286000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8234000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
212000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9780000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3236000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32572000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31160000 USD
CY2022Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
328493000 USD
CY2021Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
0 USD
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
7499000 USD
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
7242000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
32820000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
0 USD
CY2022Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
1168000 USD
CY2021Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2022Q1 xhr Proceeds From Performance Guaranty Payments
ProceedsFromPerformanceGuarantyPayments
912000 USD
CY2021Q1 xhr Proceeds From Performance Guaranty Payments
ProceedsFromPerformanceGuarantyPayments
695000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-301092000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6547000 USD
CY2022Q1 xhr Repayments Of Secured Debt Payoffs
RepaymentsOfSecuredDebtPayoffs
65000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1854000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-334996000 USD
CY2021Q1 xhr Repayments Of Secured Debt Payoffs
RepaymentsOfSecuredDebtPayoffs
0 USD
CY2022Q1 xhr Repayments Of Secured Debt Principal Payments
RepaymentsOfSecuredDebtPrincipalPayments
932000 USD
CY2021Q1 xhr Repayments Of Secured Debt Principal Payments
RepaymentsOfSecuredDebtPrincipalPayments
1357000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
490000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
443000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66476000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39561000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
554231000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
428786000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219235000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
389225000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179077000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
354597000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40158000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
34628000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219235000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
389225000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
21433000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
24814000 USD
CY2022Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 USD
CY2021Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
72000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2891000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
368000 USD
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
Organization<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia Hotels &amp; Resorts, Inc. (the "Company" or "Xenia") is a Maryland corporation that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company's assets are held by, and all the operations are conducted through, XHR LP (the "Operating Partnership"). XHR GP, Inc. is the sole general partner of XHR LP and is wholly-owned by the Company. As of March 31, 2022, the Company collectively owned 97.1% of the common limited partnership units issued by the Operating Partnership ("Operating Partnership Units"). The remaining 2.9% of the Operating Partnership Units are owned by the other limited partners comprised of certain of our current executive officers and members of our Board of Directors and includes vested and unvested long-term incentive plan ("LTIP") partnership units. LTIP partnership units may or may not vest based on the passage of time and whether certain market-based performance objectives are met. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia operates as a real estate investment trust ("REIT"). To qualify as a REIT the Company cannot operate or manage its hotels. Therefore, the Operating Partnership and its subsidiaries lease the hotel properties to XHR Holding, Inc. and its subsidiaries (collectively with its subsidiaries, "XHR Holding"), the Company's taxable REIT subsidiary ("TRS"), which engages third-party eligible independent contractors to manage the hotels. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022 and 2021, the Company owned 34 and 35 lodging properties, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ongoing Impact of COVID-19 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began to see improvements in leisure demand during the second half of 2020, a trend that accelerated in 2021 and has continued into 2022. During the first quarter of 2022, operations continued to improve due to a re-acceleration in leisure travel and higher levels of business transient and group demand beginning in mid-February.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite this improvement, there remains significant uncertainty regarding the pace of recovery and whether and when business travel and larger group meetings will return to pre-pandemic levels. We may be impacted by, among other things, the distribution and acceptance of COVID-19 vaccines and boosters, breakthrough cases, and new variants of COVID-19, as well as the ongoing local and national response to the virus. As the recovery continues, we expect that the pace will vary from market to market and may be uneven in nature.</span></div>
CY2022Q1 xhr Number Of Top Lodging Markets For Investing
NumberOfTopLodgingMarketsForInvesting
25 market
CY2022Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
34 property
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
35 property
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management's best judgment, after considering past, current and expected future economic conditions. Actual results could differ from these estimates.</span></div>
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risks and Uncertainties</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pandemic, the majority of the Company's hotels and resorts temporarily suspended operations for certain periods of time during 2020. All of the Company's hotels had resumed operations by the end of May 2021. The Company's portfolio consists of luxury and upper upscale hotels and resorts, which generally offer restaurant and bar venues, large meeting facilities and event space, and amenities, including spas and golf courses, some of which may have limited operations or may not be able to operate during the recovery in order to comply with implemented safety measures, ongoing or reimplemented restrictions and to accommodate reduced levels of demand. The Company continues to monitor the evolving situation and guidance from federal, state and local governmental and public health authorities and additional actions may be taken or required based on their recommendations and regulations in place. Under these circumstances, there may be developments that require further adjustments to operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict with certainty whether and when business levels will return to normalized levels after the effects of the pandemic subside or whether hotels will be forced to suspend operations or impose additional restrictions due to future variants of COVID-19. Although it is improving, the lodging industry, particularly with respect to business transient and group business, has continued to lag behind the recovery of other industries. Factors such as public health (including a significant increase in variant strains of COVID-19 cases), availability and effectiveness of COVID-19 vaccines/boosters and therapeutics, the level of acceptance of the vaccine by the general population and the economic and geopolitical environments may impact the timing, extent and pace of such recovery. Additionally, the effects of the pandemic could materially and adversely affect the Company's ability to consummate acquisitions and dispositions of hotel properties in the near term.</span></div>The Company cannot predict with certainty the full extent and duration of the effects of the COVID-19 pandemic on its business, operating margins, results of operations, cash flows, financial condition, the market price of its common stock, its ability to make distributions to its shareholders, its access to equity and credit markets or its ability to service its indebtedness. Further, the Company continues to monitor and evaluate the challenges associated with inflationary pressures, the evolving workforce landscape, particularly related to industry-wide labor shortages and expected increases in wages, as well as ongoing supply chain issues which may continue to impact the hotels' ability to source operating supplies and other materials.
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
210347000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87852000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
18990000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
20307000 USD
CY2022Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0518
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1429616000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1494231000 USD
CY2022Q1 xhr Derivative Number Of Instruments Terminated
DerivativeNumberOfInstrumentsTerminated
2 derivative_instrument
CY2022Q1 xhr Debt Instrument Carrying Amount And Line Of Credit
DebtInstrumentCarryingAmountAndLineOfCredit
1449000000 USD
CY2021Q4 xhr Debt Instrument Carrying Amount And Line Of Credit
DebtInstrumentCarryingAmountAndLineOfCredit
1515000000 USD
CY2022Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0518
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3632000 USD
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYearWeightedAverageInterestRate
0.0408
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5537000 USD
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year One Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearOneWeightedAverageInterestRate
0.0413
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
280160000 USD
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year Two Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoWeightedAverageInterestRate
0.0394
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
503512000 USD
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year Three Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeWeightedAverageInterestRate
0.0636
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
54379000 USD
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal In Year Four Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourWeightedAverageInterestRate
0.0453
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
601386000 USD
CY2022Q1 xhr Long Term Debt Maturities Repayments Of Principal After Year Four Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFourWeightedAverageInterestRate
0.0483
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1448606000 USD
CY2022Q1 xhr Long Term Debt Gross Weighted Average Interest Rate
LongTermDebtGrossWeightedAverageInterestRate
0.0518
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0300
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
18990000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1429616000 USD
CY2022Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0518
CY2022Q1 xhr Number Of Mortgage Loans Repaid
NumberOfMortgageLoansRepaid
1 loan
CY2022Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
300000 USD
CY2022Q1 xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
-1600000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2517000 USD
CY2022Q1 xhr Derivative Number Of Instruments Terminated
DerivativeNumberOfInstrumentsTerminated
2 derivative_instrument
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
104000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1152000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-2330000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
20538000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
18750000 USD
CY2022Q1 xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
-1555000 USD
CY2021Q1 xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
0 USD
CY2022Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
-800000 USD
CY2022Q1 xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.1600
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000 USD
CY2021Q1 xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.0245
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 USD
CY2022Q1 xhr Common Stock Maximum Authorized Pursuant To At The Market Agreements Value
CommonStockMaximumAuthorizedPursuantToAtTheMarketAgreementsValue
200000000 USD
CY2022Q1 xhr Common Stock Remaining Available Pursuant To At The Market Agreements Value
CommonStockRemainingAvailablePursuantToAtTheMarketAgreementsValue
200000000 USD
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5324000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5324000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-56351000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56351000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114326406 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113780388 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114326406 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113780388 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
423043 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
546124 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1762044 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1057984 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
153064 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2666964 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.86
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
20700000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M24D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P21Y
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0570
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19366000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
20637000 USD
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
537000 USD
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
812000 USD
CY2022Q1 us-gaap Lease Cost
LeaseCost
1349000 USD
CY2022Q1 xhr Operating Lease Including Available Extension Options Weighted Average Remaining Lease Term
OperatingLeaseIncludingAvailableExtensionOptionsWeightedAverageRemainingLeaseTerm
P56Y
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1596000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2142000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2157000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2172000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2188000 USD
CY2022Q1 xhr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
26648000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
36903000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16266000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
20637000 USD

Files In Submission

Name View Source Status
0001616000-22-000073-index-headers.html Edgar Link pending
0001616000-22-000073-index.html Edgar Link pending
0001616000-22-000073.txt Edgar Link pending
0001616000-22-000073-xbrl.zip Edgar Link pending
exhibit21wnashvillepsa.htm Edgar Link pending
exhibit311_2022q1x10q.htm Edgar Link pending
exhibit312_2022q1x10q.htm Edgar Link pending
exhibit321_2022q1x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xhr-20220331.htm Edgar Link pending
xhr-20220331.xsd Edgar Link pending
xhr-20220331_cal.xml Edgar Link unprocessable
xhr-20220331_def.xml Edgar Link unprocessable
xhr-20220331_htm.xml Edgar Link completed
xhr-20220331_lab.xml Edgar Link unprocessable
xhr-20220331_pre.xml Edgar Link unprocessable